The GWAS discovered MI risk variant at 6p24 in the protein phosphatase 1 regulator gene (PHACTR1) is associated with adverse arterial wave reflection indexes and may mediate MI risk through this pathway.
Heritable factors play a key role in the development of coronary heart disease. 1 Early unbiased genome-wide approaches have led to the identification of more than a dozen novel risk loci for myocardial infarction (MI) in predominantly Caucasian cohorts. [2] [3] [4] [5] [6] [7] [8] Many loci have replicated in large cohorts, yet of these only four appear to have a mechanistically relevant basis through lipid metabolism pathways (1p13, 1p32, 19p13, 6q26). 9, 10 The remaining loci span genomic regions that as yet have no clearly defined mechanism to explain MI risk.
Valuable insights into the functions of these variants may be gleaned by studying their effects on related or intermediate phenotypes which may be causal in the pathway to developing MI. This is best illustrated by the initial association of 1p13 with MI and then with the intermediate phenotype of lipid levels, with subsequent functional studies identifying its role in cellular cholesterol transport through the sortillin protein. 11 Another intermediate phenotype of interest in vascular disease is abnormal pressure wave reflection within the arterial tree. Abnormalities in these arterial tree properties occur due to complex composite changes in parameters such as arterial stiffness and vasomotor tone, ultimately leading to increased left ventricular after-load and cardiovascular events such as myocardial ischemia, MI, and stroke. [12] [13] [14] [15] We therefore investigated the association of variants at eight MI risk loci, whose mechanisms of action are currently unknown, with noninvasively derived pulse wave analysis (PWA) indexes Background Genome-wide association studies (GWAS) have identified novel variants associated with myocardial infarction (MI) in Caucasians. We hypothesized that those variants whose mechanism of risk is currently unknown, confer risk via pathways mediating arterial wave reflections which is an increasingly recognized risk factor for cardiovascular disease.
Methods
Single-nucleotide polymorphisms (SNPs) at eight MI risk loci were genotyped and correlated with noninvasively determined pulse wave analysis (PWA)-derived central hemodynamic indexes (augmentation index (AIx); augmented pressure (AP); time to reflected wave (TrW) and central systolic blood pressure (SBP) and diastolic BP (DBP)) in two independent Caucasian populations including (i) those free of measured cardiovascular risk factors (n = 133) and (ii) a community-based population (n = 270).
results
Of the eight SNPs examined in the healthy group, the variants at loci 6p24 (AIx and AP both P < 0.001, TrW P = 0.02) and 21q22 (AIx P = 0.002, TrW P = 0.037) were significantly associated with PWA indexes. In the replication group, only the 6p24 variant correlated with these phenotypes (AIx P = 0.005, AP P = 0.049, TrW P = 0.013). In the pooled population (n = 403), no new associations were identified but the association with 6p24 and AIx remained significant even after Bonferroni correction and adjustment for covariates including age, mean arterial pressure, height, gender, glucose, cholesterol, body mass index (BMI), and smoking (AIx (P = 0.03)). Each copy of the risk allele C increased the AIx by 3.5%.
original contributions 6p24 and Central Hemodynamic Indexes including the magnitude and timing of reflected arterial pressure waveforms in two separate Caucasian populations. The first consisting of very healthy subjects, free of confounding risk factors to enable an assessment of direct genetic risk and the second, an unselected community-based population that allowed determination of genetic effects in the context of common risk factors. We hypothesized that some or all of these markers would demonstrate association with indexes of adverse arterial wave reflection.
Methods
Subjects. Two populations were studied ( Table 1) . Group 1 was derived from a healthy sample of subjects free of cardiovascular risk factors enrolled in the Predictive Medicine (PreMed) study. 16 This group was chosen to minimize confounding from coronary artery disease, medication usage, and other risk factors. Healthy nonsmoking, normal weight (body mass index (BMI) <26 kg/m 2 ) volunteers aged 20-70 years were recruited after careful screening for absence of hypertension (systolic blood pressure (SBP) <130 or diastolic BP (DBP) <90 mm Hg × 3), hyperlipidemia (total cholesterol <200 mg/dl, lowdensity lipoprotein <120 mg/dl), and impaired fasting glucose or diabetes (fasting glucose <100 mg/dl). A total of 133 eligible Caucasian subjects underwent vascular studies and blood draws for genotyping.
Group 2 was derived from the Morehouse and Emory Team up to Eliminate Health Disparities (META-Health) study, which is a cross-sectional survey of residents in the Atlanta metropolitan area who were invited for assessment of their BP, vascular health, biomarkers, and anthropometric measures, in addition to a series of health questionnaires. These subjects were unselected and recruited by random telephone dialing so as to be representative of the local community. Full details have been published previously. 17 History of diabetes, hypertension, cardiovascular disease (coronary artery disease, MI or stroke), and smoking status were defined by participant self report. Subjects of self-reported non-Caucasian race or with documented cardiovascular disease were excluded, allowing inclusion of 270 Caucasian subjects.
Subjects were sampled consecutively and without selection from each study, both of which were approved by the Emory University or Morehouse Institutional Review Boards, and informed consent was obtained from all subjects.
Central hemodynamic indexes. All indexes were estimated using noninvasive Sphygmocor technology (Atcor Medical, Sydney, Australia) in a quiet temperature controlled room after an overnight fast. PWA was performed by recording sequential high quality pressure waveforms at the radial artery using a highly sensitive tonometer. The device applies a proprietary transfer function to this peripheral measurement to estimate central (proximal) aortic pressure waveforms. This permits estimation of central (aortic) pressures, pressure augmentation secondary to wave reflections (augmented pressure, AP) and the augmentation index (AP/total central pulse pressure, AIx), which is widely considered to be a complex composite measure of wave reflection properties of the arterial tree. Due to its sensitivity to heart rate, a standardized value to 75 bpm (beats per minute) was used for the purposes of this study as advocated by Wilkinson et al. 18 Time to reflected wave (TrW) is an indirect measure of stiffness derived from analysis of the pressure wave form and is a measure of the time taken (in ms) for the reflected wave to return from the periphery and merge with the incident wave, where a shorter time indicates faster wave travel, and thus greater arterial stiffness.
Quality control indexes were evaluated at the time of study and non-acceptable readings discarded and repeated. Three readings were taken for each subject and averaged for analysis. Reproducibility studies in our laboratory on nine subjects on consecutive days, by the same operators performing 19 Another four loci have potential functional relevance to lipid metabolism (1p13-SORT1; 19p13-LDLR; 1p32-PCSK9; 6q26-LpA) and were therefore not included in this study, as we proposed to examine those loci without any obvious mechanism. 9, 10, 20 One singlenucleotide polymorphism (SNP) at 12q24.3 was not included due to its very small effect size in the discovery study. 6 Lead SNPs, defined by the original GWAS reports, at the remaining eight loci of interest, which are independent of traditional risk factors, were thus genotyped and are listed in Supplementary  Table S1 online. Genotyping for both PreMed and META-Health subjects was performed using the SNPstream (Beckman Coulter, Fullerton, CA) 48 plex platform at the Emory University Biomarker Center as part of other candidate gene studies. 21, 22 The GenomeLab SNPstream Genotyping System Software Suite v2.3 (Beckman Coulter) was used for array imaging and genotype calling. To ensure genotyping accuracy and reproducibility two internal quality control samples were included and each run in triplicate, on each of the 384-well arrays. Genotyping rate for all eight SNPs was >98%.
Statistical methods. All continuous variables are described as mean ± s.d., while categorical variables are presented as proportions. The distribution of all variables was tested for normality and none required prior transformation. All SNPs were tested for Hardy-Weinberg equilibrium using PLINK. 23 Association tests for quantitative vascular traits were performed using linear regression. SNPs were modeled as independent variables assuming an additive model of inheritance and coded on number of risk alleles as 0, 1 or 2. We tested each SNP for association with the arterial indexes separately in each subject group and then in the total combined group to increase statistical power and reduce type 1 error. Bonferroni adjustment for eight genotypes and five phenotypes (P value × 13) was performed in the pooled analyses, as well as adjustment for age, mean arterial pressure, and height in model 1 which are major determinants of PWA indexes, in addition to gender, glucose, total cholesterol, BMI, and smoking status in model 2.
Two-tailed P values of <0.05 were considered significant. Bonferroni correction for multiple testing was performed for the eight genotypes and five phenotypes tested (P value × 13). All analyses were performed using PLINK 23 and SPSS v17.0 statistical package (SPSS, Chicago, IL).
Power calculations. We estimated the effect sizes that would be observed at a fixed power of 80% and an α of 0.05. Varying the risk allele frequency from the least frequent to most frequent, 0.10-0.45, we estimated that under an additive model, our pooled sample size (n = 403) would allow us to identify effect sizes per risk allele of 2.7-4.4% for AIx; 1.0-1.7 mm Hg for AP, and 3.5-5.5 ms for TrW.
results
Patient characteristics for the Caucasian subjects in PreMed (n = 133) who were healthy and free of all cardiovascular risk factors and for those in META-Health (n = 270) are presented in Table 1 . Compared to PreMed, subjects in META-Health were older, more likely to be female and almost a third had either hypertension and/or hyperlipidemia, 5% were diabetic, and 13% were current smokers. As expected the central hemodynamic indexes were more impaired for subjects in METAHealth compared to those in PreMed (all P < 0.01) ( Table 1) . Characteristics for the pooled population are also presented in Table 1 . The distribution of genotypes and allele frequencies in each group for the eight risk variants were in Hardy-Weinberg equilibrium, with allele frequencies similar to published data for Caucasians (Supplementary Table S1 online).
association with vascular traits
We analyzed the association of these variants with the main quantitative vascular traits, AIx and AP (both standardized to a heart rate of 75 bpm, AIx/AP), TrW, and central SBP and DBP in each study population separately and then combined. The association findings for AIx, AP, and TrW are presented in Tables 2-4 .
(i) PreMed The most prominent finding in the PreMed group was the association of the variant at 6p24 with three of the five studied central hemodynamic parameters (Tables 2-4) . The MI risk allele (C) was associated with worse (higher) AIx (P < 0.001), (higher) AP (P = 0.001), and (lower) TrW (P = 0.023), but not central BP (systolic P = 0.36, diastolic P = 0.42). The strongest association was with AIx for which each copy of the risk allele increased the AIx by nearly 7% (β 6.88, P < 0.001) ( Table 2) .
Additionally the variant at the 21q22 locus had significant association with AIx (P = 0.002), AP (P = 0.024), and TrW (P = 0.037) but not central BP, while the variant at 12q24 showed a borderline trend towards association with AIx (P = 0.05) and AP (P = 0.09) (Tables 2-4) .
(ii) META-Health Of the eight SNPs tested in this population, only the 6p24 variant showed significant association with AIx (P = 0.005), AP (P = 0.049), TrW (P = 0.013) (Tables 2-4) . Again, this association was not significant for central SBP (P = 0.37) or DBP (P = 0.45). Neither the 12q24 nor 21q22 loci which had demonstrated modest association in the PreMed cohort, nor any other loci showed any significant association with any phenotypes in this cohort.
(iii) Combined analysis To minimize a type 1 error we combined the two cohorts for a final analysis. The pooled cohort of 403 subjects showed a significant association between the 6p24 variant and AIx original contributions 6p24 and Central Hemodynamic Indexes (P = 0.001), AP (P = 0.005), TrW (P = 0.002) (Tables 2-4) . The risk allele C conferred a 3.5% increase in AIx per risk allele. This equates to a mean AIx value of 18.4% in the homozygote risk group compared to 12.7% in the referent non-risk GG group (Figure 1) . The association remained significant after adjustment for multiple testing for eight variants and five phenotypes (Tables 2-4) . Furthermore, after adjustment for age, mean arterial pressure, and height, which are the strongest determinants of these parameters (model 1), the association persisted for AIx and TrW but was weakened for AP (Tables 2-4) . After additional adjustment for model 1 parameters and other risk factors which could influence these indexes, including gender, glucose, total cholesterol, BMI, and smoking (model 2), only AIx remained significantly associated with the marker at 6p24, while the association was attenuated to borderline for TrW and nonsignificance for AP (Tables 2-4) . Finally, we did not observe significant interactions between the 6p24 marker and the tested covariates (data not shown).
Of the remaining variants tested for association in the larger pooled cohort (n = 403) no further significant associations were identified with any phenotype (Tables 2-4 ).
discussion
In order to explore potential mechanistic pathways of newly identified genetic variants associating with MI, whose function is currently unknown, we investigated their relationship with the intermediate phenotype of PWA indexes. We demonstrate that the MI risk locus at chromosome 6p24 in the PHACTR1 gene, identified through GWAS of early onset MI, is significantly associated with abnormal wave reflection properties of the arterial tree in two independent cohorts.
In this study, the risk allele (C) of the 6p24 variant (rs12526453) was associated with greater AIx, AP, and TrW in a healthy cohort free from confounding risk factors or medications, and replicated in a larger community population sample. The association with AIx appeared most robust, with homozygotes having an average value of 18.6% compared to the referent group mean of 12.7%. AIx is considered a complex measure of wave reflections and elasticity of the muscular arteries, all of which could be considered as representing small vessel or systemic arterial stiffness. Furthermore, the TrW is also considered a surrogate of large artery stiffness. 24 Importantly abnormalities in central hemodynamic indexes including AIx are powerful predictors of cardiovascular morbidity and mortality. A recent meta-analysis of population cohorts confirms that a 10% rise in AIx confers ~30% increase in risk for all cause mortality. 15 Thus, the independent association of this 6p24 variant with several related central hemodynamic indexes suggests that it may mediate risk of MI by modulating arterial elastic properties and pressure wave reflections.
Interestingly, we did not observe any association with central SBP or DBP in either study cohort. This is perhaps not surprising, given that AIx has been shown to be considerably more heritable than BP. For example in a study of twins, Snieder et al. demonstrated a heritability of 37% for AIx, but only 13-25% for BP traits, while others have found estimates as high as 62% for AIx. 25, 26 This is likely due to the fact that arterial elastic properties are just one determinant of BP and genetic variants are more likely to explain greater variance in these upstream components than in the final composite phenotype.
Although there were promising initial associations between at least two other SNPs at 12q24 and 21q22 with these parameters, none were successfully replicated in the second cohort with risk factors. Other variants did not associate significantly with any phenotype although this could be explained by lack of statistical power to detect much smaller effect sizes.
The rs12526543 SNP resides on the short arm of chromosome 6, in the untranslated portion of the PHACTR1 gene but is in linkage disequilibrium with several neighboring SNPs within this gene (Supplementary Figure S1 online). PHACTR1 codes for phosphatase and actin regulator 1, which is one of many regulating proteins for the protein phosphatase 1 (PP1) enzyme. 27 The latter is a ubiquitously expressed enzyme involved in a wide array of physiological processes, including gene expression, muscle contraction, and glycogen metabolism as well as being a critical negative regulator of Ca 2+ cycling and contractility in smooth muscle cells and cardiomyocytes, which may be pertinent in the context of vasomotor tone, arterial elasticity, and wave reflections.
Genetic polymorphisms have been widely studied and associated with indexes of pressure wave reflection. 28, 29 Our study is unique in (i) following the GWAS paradigm of looking backwards to identify causal pathways, rather than an a priori candidate gene hypothesis and (ii) for using a strategy of refining the original phenotype to identify the underlying mechanistic pathway. Furthermore, a recent GWAS in 4,600 subjects identified a 100 variants associating with a related phenotype of arterial stiffness using pulse wave velocity. Two of these are in fact located in the PHACTR1 gene, just 30 kb from and in close linkage disequilibrium to rs12526453 (Supplementary Figure S1 online). 30 Our findings taken with these support the role of this gene and locus in adversely influencing arterial elastic properties as a potential mechanism leading to MI, possibly through calcium cycling and altered smooth muscle contractility. In conclusion, we have shown that the 6p24 marker, rs12526453, which was recently identified as conferring risk of MI through genome-wide association, also associates with impaired central hemodynamic indexes in two distinct populations independent of age and BP. This finding could have implications for understanding the mechanism of risk for this locus as well as opening up possible therapeutic interventions in those with the risk allele.
limitations
Limitations of our study include its cross-sectional design which restricts the conclusions we can draw regarding causality, although refining the phenotype in this manner provides some insight into potential risk pathways. Second, our restricted sample size meant that we may have missed SNP effects of a smaller magnitude than our power calculations suggested or those that have interactions with environmental factors. While we combined cohorts to maximize power in the pooled analysis, we accept that the significant baseline differences in the characteristics of the cohorts may have introduced some heterogeneity and bias. We were also unable to adjust for other possible confounders which could influence the studied indexes such as menopause status of female participants or specific medication effects for those in the META-Health group with risk factors. On the other hand the nature of our study necessitates multiple testing, which could lead to falsepositive findings. However, some degree of confidence in our findings is provided by their persistence despite conservative Bonferroni adjustment, as well as the fact that the association with 6p24 was with several linked parameters in two distinct populations which was apparent even with relatively small sample sizes. Finally, we did not have sufficient data to examine association with pulse wave velocity, an independent and gold standard measure of large artery stiffness, to differentiate if the observed effects were due primarily to enhanced stiffness. 30 implications GWAS have identified multiple variants associating with MI, but mechanisms of risk remain poorly understood. For 6p24, if MI risk is confirmed to be mediated via impaired arterial elastic properties then this could have significant treatment implications. First, existing therapies known to modulate wave reflections could be used to try and ameliorate risk in those with the 6p24 variant in a personalized genotype-targeted manner. Second, new treatments targeting the PHACTR1 gene, modulating calcium regulation may offer a new approach to reducing wave reflections and reducing risk associated with pressure augmentation in the broader population.
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